Trepo C - Search Results

1

Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.

Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A, Kew MC, Trepo C, Wands JR. Merle P, et al. Among authors: trepo c. Gastroenterology. 2004 Oct;127(4):1110-22. doi: 10.1053/j.gastro.2004.07.009. Gastroenterology. 2004. PMID: 15480989

2

Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.

Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR. Merle P, et al. Among authors: trepo c. J Hepatol. 2005 Nov;43(5):854-62. doi: 10.1016/j.jhep.2005.05.018. Epub 2005 Jun 21. J Hepatol. 2005. PMID: 16098625

3

Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma.

Nambotin SB, Lefrancois L, Sainsily X, Berthillon P, Kim M, Wands JR, Chevallier M, Jalinot P, Scoazec JY, Trepo C, Zoulim F, Merle P. Nambotin SB, et al. Among authors: trepo c. J Hepatol. 2011 Feb;54(2):288-99. doi: 10.1016/j.jhep.2010.06.033. Epub 2010 Sep 16. J Hepatol. 2011. PMID: 21055837

4

Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Trépo C, Wands J, Tong S. Parekh S, et al. Among authors: trepo c. J Virol. 2003 Jun;77(12):6601-12. doi: 10.1128/jvi.77.12.6601-6612.2003. J Virol. 2003. PMID: 12767980 Free PMC article.

5

Molecular mechanisms underlying hepatocellular carcinoma.

Merle P, Trepo C. Merle P, et al. Among authors: trepo c. Viruses. 2009 Dec;1(3):852-72. doi: 10.3390/v1030852. Epub 2009 Nov 9. Viruses. 2009. PMID: 21994573 Free PMC article.

6

Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.

Mornex F, Girard N, Beziat C, Kubas A, Khodri M, Trepo C, Merle P. Mornex F, et al. Among authors: trepo c. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1152-8. doi: 10.1016/j.ijrobp.2006.06.015. Int J Radiat Oncol Biol Phys. 2006. PMID: 17145534 Clinical Trial.

7

Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus.

Fournillier A, Freida D, Defrance T, Merle P, Trépo C, Inchauspé G. Fournillier A, et al. Among authors: trepo c. J Med Virol. 2004 Apr;72(4):566-74. doi: 10.1002/jmv.20039. J Med Virol. 2004. PMID: 14981759

8

Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo.

Barraud L, Merle P, Soma E, Lefrançois L, Guerret S, Chevallier M, Dubernet C, Couvreur P, Trépo C, Vitvitski L. Barraud L, et al. Among authors: trepo c. J Hepatol. 2005 May;42(5):736-43. doi: 10.1016/j.jhep.2004.12.035. J Hepatol. 2005. PMID: 15826724

9

Long-term high-dose interferon-alpha therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice.

Merle P, Barraud L, Lefrançois L, Chevallier M, Guerret S, Maisonnas M, Bordes I, Savre-Train I, Trepo C, Vitvitski-Trepo L. Merle P, et al. Among authors: trepo c. Oncogene. 2003 May 8;22(18):2762-71. doi: 10.1038/sj.onc.1206375. Oncogene. 2003. PMID: 12743599

10

Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.

Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, Trepo C, Kay A. Jeantet D, et al. Among authors: trepo c. J Med Virol. 2004 Aug;73(4):508-15. doi: 10.1002/jmv.20119. J Med Virol. 2004. PMID: 15221893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

794 results

Search Page